Elevated skeletal muscle phosphodiesters in adults using statin medications
- 31 July 2006
- journal article
- Published by Wiley in Muscle & Nerve
- Vol. 34 (6) , 782-784
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Underappreciated Statin-Induced Myopathic Weakness Causes DisabilityNeurorehabilitation and Neural Repair, 2005
- Molecular clues into the pathogenesis of statin‐mediated muscle toxicityMuscle & Nerve, 2005
- Statin-Associated Myopathy with Normal Creatine Kinase LevelsAnnals of Internal Medicine, 2002
- Membrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipidsJournal of Neural Transmission, 2000
- 31Phosphorus magnetic resonance spectroscopy in the assessment of head and neck tumorsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1998
- Acidosis has no effect on the ATP cost of contraction in cat fast- and slow-twitch skeletal musclesAmerican Journal of Physiology-Cell Physiology, 1997
- Muscle metabolism in track athletes, using 31P magnetic resonance spectroscopyCanadian Journal of Physiology and Pharmacology, 1992
- 31 P NMR studies in Duchenne muscular dystrophyNeurology, 1987
- Generation of phosphodiesters during fast-to-slow muscle transformation A 31P-NMR studyBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1982
- Phosphorus-31 nuclear magnetic resonance detection of unexpected phosphodiesters in muscleBiochemistry, 1976